Cadila Healthcare arm gets USFDA nod for ulcer treatment injection

NEW DELHI: Drug firm Cadila Healthcare Tuesday said its subsidiary has received approval from the US health regulator to market Ranitidine injection, used to treat stomach and duodenal (intestinal) ulcers.

Liva Pharmaceuticals, a wholly-owned subsidiary of Cadila Healthcare, has received approval from the US Food and Drug Administration (USFDA) for its supplemental abbreviated new drug application, Ranitidine Injection USP, 25 mg/mL, 2 mL single dose vials and 6 mL multi-dose vials, Cadila Healthcare said in a BSE filing.

Cadila Healthcare said the product will be manufactured at Liva Pharma’s manufacturing facility at Vadodara, and is the first product to be approved from this site for marketing in the US.

The company has more than 237 approvals, and has so far filed over 340 abbreviated new drug applications (ANDAs) since it commenced filings in 2003-04.

  • Related Posts

    Inquiry reveals ‘fake credentials, illegal diagnostic centres’ in Pilibhit; report sent to DM

    Pilibhit: A joint inquiry by the chief medical officer and city magistrate has found alleged statutory violations at several private diagnostic centres and nursing homes in Pilibhit district. A report…

    Medical devices PLI scheme drives local output of MRI, CT scanners, heart valves: Centre

    According to the ministry, the scheme has facilitated the establishment of domestic manufacturing capabilities for a range of high-end medical devices that were earlier predominantly imported. New Delhi: The Product…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Inquiry reveals ‘fake credentials, illegal diagnostic centres’ in Pilibhit; report sent to DM

    Inquiry reveals ‘fake credentials, illegal diagnostic centres’ in Pilibhit; report sent to DM

    Medical devices PLI scheme drives local output of MRI, CT scanners, heart valves: Centre

    Medical devices PLI scheme drives local output of MRI, CT scanners, heart valves: Centre

    MPSC Drug Inspector paper leak: 4 more arrested, total arrests rise to 11

    MPSC Drug Inspector paper leak: 4 more arrested, total arrests rise to 11

    Arogya Manthan 2026 to launch new digital health and health assurance initiatives

    Arogya Manthan 2026 to launch new digital health and health assurance initiatives

    Bengaluru drug scam: Rs 12cr spurious Pfizer stock sold to hospitals since Feb 2025; kingpin among 8 held

    Bengaluru drug scam: Rs 12cr spurious Pfizer stock sold to hospitals since Feb 2025; kingpin among 8 held

    Banned in India, sold in Maharashtra: Man held over fake Pakistani beauty cream

    Banned in India, sold in Maharashtra: Man held over fake Pakistani beauty cream